Valuation : Zenotech Laboratories Limited

Market Cap 2.09B 22.05M 19.02M 17.89M 16.3M 30.65M 30.82M 212M 82.33M 1.06B 82.79M 80.99M 3.53B P/E 2024
43.5x
P/E 2025 56.5x
Enterprise Value 1.83B 19.24M 16.59M 15.61M 14.22M 26.74M 26.89M 185M 71.82M 929M 72.22M 70.66M 3.08B EV / Sales 2024
9.27x
EV / Sales 2025 7.42x
Free-Float
15.47%
Yield 2024 *
-
Yield 2025 -
07-28 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
04-29 Zenotech Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
01-23 Zenotech Laboratories Limited Announces Cessation of Chintan Jitendra Shah as Independent Director, Chairman of the Nomination and Remuneration Committee, Member of Audit Committee/ Stakeholders Relationship Committee and Reconstitution of Board Committees CI
01-23 Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
25-10-31 Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
25-09-25 Zenotech Laboratories Limited Announces Updation of Address of the Registered Office CI
25-07-28 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
25-03-30 Zenotech Laboratories Limited Announces Cessation of Kavita Rakesh Shah as Independent Director, with Effect from April 01, 2025 CI
25-01-28 Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
24-10-23 Zenotech Laboratories Limited Appoints Dr. Sachin Laxmanappa Gavandare as Chief Executive Officer (Key Managerial Personnel) CI
24-10-23 Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
24-07-26 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
24-05-17 Zenotech Laboratories Limited Announces Resignation of Devendra Chandrakant Shenvi Kenkre as Chief Executive Officer, Effective August 12, 2024 CI
1 day+0.32%
1 week+1.44%
Current month+0.32%
1 month+4.18%
3 months+6.11%
6 months+2.84%
Current year+0.45%
1 week 44.71
Extreme 44.71
50
1 month 43
Extreme 43
50
Current year 33.55
Extreme 33.55
50.93
1 year 33.55
Extreme 33.55
57.9
3 years 33.55
Extreme 33.55
107.79
5 years 33.55
Extreme 33.55
107.79
10 years 12
Extreme 12
107.79
Manager TitleAgeSince
Chief Executive Officer - 2024-10-22
Director of Finance/CFO - 2014-02-05
Compliance Officer 46 2016-03-10
Director TitleAgeSince
Director/Board Member 58 2015-07-07
Chairman 67 -
Director/Board Member 42 2016-01-26
Change 5-day change 1-year change 3-year change Capi.($)
+0.32%+1.44%-17.72%-14.26% 29.67M
+0.28%-5.97%+58.34%+108.22% 1,031B
+2.01%-0.71%+53.07%+68.99% 641B
+1.39%-2.18%+23.57%+75.43% 453B
-1.50%-7.04%+33.55%+33.94% 349B
+6.25%+2.04%+28.97%+46.57% 290B
-0.07%-4.12%+0.95%+11.79% 252B
+1.92%-0.93%+52.28%+70.67% 232B
+0.51%-4.52%-19.50%-54.83% 201B
+2.45%+0.77%+32.71%+95.59% 181B
Average +1.49%-2.45%+24.62%+44.21% 362.98B
Weighted average by Cap. +1.60%-3.40%+38.39%+66.40%

Financials

2024 2025
Net sales 368M 3.88M 3.35M 3.15M 2.87M 5.39M 5.42M 37.2M 14.48M 187M 14.56M 14.25M 621M 391M 4.12M 3.55M 3.34M 3.05M 5.73M 5.76M 39.52M 15.38M 199M 15.47M 15.13M 659M
Net income 82.99M 874K 754K 710K 646K 1.22M 1.22M 8.39M 3.26M 42.21M 3.28M 3.21M 140M 56.13M 591K 510K 480K 437K 822K 827K 5.67M 2.21M 28.55M 2.22M 2.17M 94.67M
Net Debt -197M -2.07M -1.79M -1.68M -1.53M -2.88M -2.9M -19.9M -7.75M -100M -7.79M -7.62M -332M -267M -2.81M -2.43M -2.28M -2.08M -3.91M -3.93M -26.99M -10.51M -136M -10.56M -10.34M -450M
Logo Zenotech Laboratories Limited
Zenotech Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in a business of manufacture and marketing of pharmaceuticals products. The Company is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing oncology, biotechnology and general injectables products. The Company’s injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. Its product includes granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). The Company has a manufacturing facility at Turkapally village, Shamirpet Mandal, Telangana.
Employees
228
Date Price Change Volume
26-09-01 ₹46.40 +0.32% 2,395
26-08-31 ₹46.25 -1.47% 4,980
26-08-28 ₹46.94 +4.13% 41,762
26-08-27 ₹45.08 -0.49% 9,736
26-08-26 ₹45.30 -0.96% 8,916
  1. Stock Market
  2. Stocks
  3. ZENOTECH6 Stock